ID   CRO-AP6
AC   CVCL_1811
SY   CRO-AP/6; AP6
DR   BioSample; SAMN03473463
DR   DSMZ; ACC-650
DR   DSMZCellDive; ACC-650
DR   Wikidata; Q54814510
RX   PubMed=10914556;
CC   Doubling time: 40-50 hours (PubMed=10914556); ~48 hours (DSMZ=ACC-650).
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-650
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 15,16
ST   D19S433: 15
ST   D21S11: 30
ST   D2S1338: 19,21
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 20,24
ST   Penta D: 9
ST   Penta E: 10,12
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
RX   PubMed=10914556; DOI=10.1038/sj.leu.2401802;
RA   Carbone, Antonino
RA   Cilia, Anna M.
RA   Gloghini, Annunziata
RA   Capello, Daniela
RA   Fassone, Lucia
RA   Perin, Tiziana
RA   Rossi, Davide
RA   Canzonieri, Vincenzo
RA   De Paoli, Paolo
RA   Vaccher, Emanuela
RA   Tirelli, Umberto
RA   Volpe, Rachele
RA   Gaidano, Gianluca
RT   "Characterization of a novel HHV-8-positive cell line reveals
RT   implications for the pathogenesis and cell cycle control of primary
RT   effusion lymphoma.";
RL   Leukemia 14:1301-1309(2000).
//